Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)
Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety, tolerance and efficacy of Posaconazole (SCH
56592) under an open label, treatment protocol for subjects with invasive fungal infections:
A: which are refractory or resistant to standard antifungal therapies; B: for which there are
currently no effective therapies; C: with a prior history of serious, severe or
life-threatening toxicities while receiving antifungal therapy; D: with pre-existing organ
dysfunction which precludes the administration of standard antifungal therapies.